Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Takeda Pharmaceutical

What's Going On With Takeda Stock On Friday?

On Friday, Takeda Pharmaceutical Co Ltd's (NYSE:TAK) stock wobbled after touching as low as $14.53 during the premarket session, before bouncing back to about $15.47 at last check Friday.

Benzinga

Why Takeda no longer has an 'IT department' as part of the drug maker's digital and data transformation

Gabriele Ricci, chief data and technology officer, has been reorganizing the technology function at Takeda Pharmaceutical.

Fortune

Digitalization could be the answer to better health care for patients. But first, they need to trust it

Takeda Pharmaceutical chief digital trust officer Mike Towers says his industry has been slow to adapt, but is accelerating fast.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2022

Upgrades

Benzinga

Looking Into Takeda Pharmaceutical's Recent Short Interest

Takeda Pharmaceutical's (NYSE:TAK) short percent of float has fallen 13.33% since its last report. The company recently reported that it has 4.06 million shares sold short, which is 0.13% of all regular shares that are available for trading.

Organisations

Pioneer Natural Resources

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Health Care

3,089 stories

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.